Max Robotics — Global Service Robot Directory + US Certification

About

Simon Horenblas is a pioneering urologic surgeon whose research has fundamentally advanced the surgical management of urologic cancers, particularly prostate and bladder cancer. His major contributions lie at the intersection of precision oncology and minimally invasive surgery, with a special focus on sentinel lymph node mapping and robotic-assisted techniques. His landmark 2018 paper on a hybrid approach for sentinel lymph node identification (155 citations) revolutionized image-guided surgery by combining radio- and fluorescence-guidance, enabling more accurate cancer staging while reducing morbidity. Horenblas also made seminal contributions to robot-assisted laparoscopic prostatectomy, developing peroperative transrectal ultrasonography-guided bladder neck dissection to ease the learning curve for surgeons. His work on sentinel lymph node dissection in clinically node-negative prostate cancer patients (20 citations) helped refine patient selection for pelvic radiation therapy, improving biochemical recurrence outcomes. Additionally, his research on robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumors (16 citations) demonstrated the feasibility and safety of robotic approaches in complex post-chemotherapy settings. Horenblas’s work has been instrumental in establishing evidence-based, patient-tailored surgical strategies that minimize invasiveness while maximizing oncologic control.